Evidence map›Paper›PMID 39659362›Full record

ArticleInfectious Disease Modelling2024

Ebola virus disease model with a nonlinear incidence rate and density-dependent treatment.

Jacques Ndé Kengne, Calvin Tadmon

Abstract read
In one paragraph

Article in Infectious Disease Modelling, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Jacques Ndé KengneCommitted Mathematics Team, Research Unit in Mathematics and Applications, Department of Mathematics and Computer Science, University of Dschang, P.O. Box 67 Dschang, Cameroon.
Calvin TadmonCommitted Mathematics Team, Research Unit in Mathematics and Applications, Department of Mathematics and Computer Science, University of Dschang, P.O. Box 67 Dschang, Cameroon.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

This paper studies an Ebola epidemic model with an exponential nonlinear incidence function that considers the efficacy and the behaviour change. The current model also incorporates a new density-dependent treatment that catches the impact of the disease transmission on the treatment. Firstly, we provide a theoretical study of the nonlinear differential equations model obtained. More precisely, we derive the effective reproduction number and, under suitable conditions, prove the stability of equilibria. Afterwards, we show that the model exhibits the phenomenon of backward-bifurcation whenever the bifurcation parameter and the reproduction number are less than one. We find that the bi-stability and backward-bifurcation are not automatically connected in epidemic models. In fact, when a backward-bifurcation occurs, the disease-free equilibrium may be globally stable. Numerically, we use well-known standard tools to fit the model to the data reported for the 2018-2020 Kivu Ebola outbreak, and perform the sensitivity analysis. To control Ebola epidemics, our findings recommend a combination of a rapid behaviour change and the implementation of a proper treatment strategy with a high level of efficacy. Secondly, we propose and analyze a fractional-order Ebola epidemic model, which is an extension of the first model studied. We use the Caputo operator and construct the Grünwald-Letnikov nonstandard finite difference scheme, and show its advantages.

Indexed as

BifurcationCaputo fractional derivativeDensity-dependent treatmentEbola epidemic modelsFractional differential equationsGrünwald-letnikov nonstandard finite difference schemeSensitivity analysisStability

Identifiers

PMID39659362
PMCPMC11630645

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.